Rigel Pharmaceuticals, Inc. (RIGL)

41.50 -0.98 (-2.31%) USD  |  NASDAQ  |  Dec 16, 13:41
More

Rigel Pharmaceuticals Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Vertex Pharmaceuticals, Inc. Upgrade